메뉴 건너뛰기




Volumn 64, Issue 2, 2008, Pages 133-157

Pharmacogenetics: Data, concepts and tools to improve drug discovery and drug treatment

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; AMITRIPTYLINE; ARYLAMINE ACETYLTRANSFERASE; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR; BLOOD CLOTTING FACTOR 5; CARVEDILOL; CELECOXIB; CHOLINESTERASE; CITALOPRAM; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; DIHYDROPYRIMIDINE DEHYDROGENASE; DRUG METABOLIZING ENZYME; GLIBENCLAMIDE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HALOPERIDOL; IBUPROFEN; ISOENZYME; LANSOPRAZOLE; METOPROLOL; NATEGLINIDE; PHENPROCOUMON; THIOPURINE METHYLTRANSFERASE; TOLBUTAMIDE; TROPISETRON; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN K EPOXIDE REDUCTASE; WARFARIN;

EID: 39149092661     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-007-0424-z     Document Type: Review
Times cited : (58)

References (164)
  • 1
    • 50749093820 scopus 로고
    • The incidence of alkaptonuria: A study in chemical individuality
    • Garrod AE (1902) The incidence of alkaptonuria: a study in chemical individuality. Lancet 2:1616-1620
    • (1902) Lancet , vol.2 , pp. 1616-1620
    • Garrod, A.E.1
  • 3
    • 9544230466 scopus 로고
    • A genetic study of a defect in glutathione metabolism of the erythrocyte
    • Childs B, Zinkham WH, Browne EA et al (1958) A genetic study of a defect in glutathione metabolism of the erythrocyte. Bull Johns Hopkins Hosp 1-2:21-37
    • (1958) Bull Johns Hopkins Hosp , vol.1-2 , pp. 21-37
    • Childs, B.1    Zinkham, W.H.2    Browne, E.A.3
  • 5
    • 0019990268 scopus 로고
    • Ethnic differences in drug metabolism
    • Kalow W (1982) Ethnic differences in drug metabolism. Clin Pharmacokinet 7:373-400
    • (1982) Clin Pharmacokinet , vol.7 , pp. 373-400
    • Kalow, W.1
  • 6
    • 34250942732 scopus 로고
    • [Butyrylcholine esterase in the blood serum of man and animal.]
    • Kalow W (1952) Butyrylcholine esterase in the blood serum of man and animal. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 215:370-377
    • (1952) Naunyn Schmiedebergs Arch Exp Pathol Pharmakol , vol.215 , pp. 370-377
    • Kalow, W.1
  • 7
    • 0001103663 scopus 로고
    • Über die Erbeddingtheit der intraindividuellen Konstanz der Isoniazidausscheidung beim Menschen
    • Bönicke R, Lisboa BP (1957) Über die Erbeddingtheit der intraindividuellen Konstanz der Isoniazidausscheidung beim Menschen. Naturwissenschaften 44:314
    • (1957) Naturwissenschaften , vol.44 , pp. 314
    • Bönicke, R.1    Lisboa, B.P.2
  • 8
    • 26444539817 scopus 로고
    • Genetic control of isoniazid metabolism in man
    • Evans DA, Manley KA, Mc KV (1960) Genetic control of isoniazid metabolism in man. Br Med J 2:485-491
    • (1960) Br Med J , vol.2 , pp. 485-491
    • Evans, D.A.1    Manley, K.A.2    Mc, K.V.3
  • 9
    • 0025344002 scopus 로고
    • Human arylamine N-acetyltransferase genes: Isolation, chromosomal localization, and functional expression
    • Blum M, Grant DM, McBride W, Heim M, Meyer UA (1990) Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol 9:193-203
    • (1990) DNA Cell Biol , vol.9 , pp. 193-203
    • Blum, M.1    Grant, D.M.2    McBride, W.3    Heim, M.4    Meyer, U.A.5
  • 10
    • 0029163589 scopus 로고
    • Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: Correlation with phenotypic activity
    • Cascorbi I, Drakoulis N, Brockmöller J, Maurer A, Sperling K, Roots I (1995) Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. Am J Hum Genet 57:581-592
    • (1995) Am J Hum Genet , vol.57 , pp. 581-592
    • Cascorbi, I.1    Drakoulis, N.2    Brockmöller, J.3    Maurer, A.4    Sperling, K.5    Roots, I.6
  • 15
    • 0024796958 scopus 로고
    • The human debrisoquine 4-hydroxylase (CYP2D) locus: Sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene
    • Kimura S, Umeno M, Skoda RC, Meyer UA, Gonzalez FJ (1989) The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. Am J Hum Genet 45:889-904
    • (1989) Am J Hum Genet , vol.45 , pp. 889-904
    • Kimura, S.1    Umeno, M.2    Skoda, R.C.3    Meyer, U.A.4    Gonzalez, F.J.5
  • 16
    • 0025080352 scopus 로고
    • Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification
    • Heim M, Meyer UA (1990) Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification. Lancet 336:529-532
    • (1990) Lancet , vol.336 , pp. 529-532
    • Heim, M.1    Meyer, U.A.2
  • 17
    • 13544249943 scopus 로고    scopus 로고
    • Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): Clinical consequences, evolutionary aspects and functional diversity
    • Ingelman-Sundberg M (2005) Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J 5:6-13
    • (2005) Pharmacogenomics J , vol.5 , pp. 6-13
    • Ingelman-Sundberg, M.1
  • 18
    • 0027136288 scopus 로고
    • Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine
    • Johansson I, Lundqvist E, Bertilsson L, Dahl ML, Sjoqvist F, Ingelman-Sundberg M (1993) Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine. Proc Natl Acad Sci USA 90:11825-11829
    • (1993) Proc Natl Acad Sci USA , vol.90 , pp. 11825-11829
    • Johansson, I.1    Lundqvist, E.2    Bertilsson, L.3    Dahl, M.L.4    Sjoqvist, F.5    Ingelman-Sundberg, M.6
  • 19
    • 0031038038 scopus 로고    scopus 로고
    • Cytochrome P450 2D6 variants in a Caucasian population: Allele frequencies and phenotypic consequences
    • Sachse C, Brockmöller J, Bauer S, Roots I (1997) Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am J Hum Genet 60:284-295
    • (1997) Am J Hum Genet , vol.60 , pp. 284-295
    • Sachse, C.1    Brockmöller, J.2    Bauer, S.3    Roots, I.4
  • 20
    • 0036223831 scopus 로고    scopus 로고
    • Summary of information on human CYP enzymes: Human P450 metabolism data
    • Rendic S (2002) Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev 34:83-448
    • (2002) Drug Metab Rev , vol.34 , pp. 83-448
    • Rendic, S.1
  • 23
    • 0036797601 scopus 로고    scopus 로고
    • Contributions of CYP2D6, CYP2C9 and CYP2C19 to the biotransformation of E- and Z-doxepin in healthy volunteers
    • Kirchheiner J, Meineke I, Muller G, Roots I, Brockmoller J (2002) Contributions of CYP2D6, CYP2C9 and CYP2C19 to the biotransformation of E- and Z-doxepin in healthy volunteers. Pharmacogenetics 12:571-580
    • (2002) Pharmacogenetics , vol.12 , pp. 571-580
    • Kirchheiner, J.1    Meineke, I.2    Muller, G.3    Roots, I.4    Brockmoller, J.5
  • 25
    • 0021237993 scopus 로고
    • Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in man
    • Kupfer A, Preisig R (1984) Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man. Eur J Clin Pharmacol 26:753-759
    • (1984) Eur J Clin Pharmacol , vol.26 , pp. 753-759
    • Kupfer, A.1    Preisig, R.2
  • 27
    • 0028044085 scopus 로고
    • Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese
    • De Morais SM, Wilkinson GR, Blaisdell J, Meyer UA, Nakamura K, Goldstein JA (1994) Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol 46:594-598
    • (1994) Mol Pharmacol , vol.46 , pp. 594-598
    • De Morais, S.M.1    Wilkinson, G.R.2    Blaisdell, J.3    Meyer, U.A.4    Nakamura, K.5    Goldstein, J.A.6
  • 28
    • 0030904031 scopus 로고    scopus 로고
    • Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations
    • Goldstein JA, Ishizaki T, Chiba K, de Morais SM, Bell D, Krahn PM, Evans DA (1997) Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations. Pharmacogenetics 7:59-64
    • (1997) Pharmacogenetics , vol.7 , pp. 59-64
    • Goldstein, J.A.1    Ishizaki, T.2    Chiba, K.3    De Morais, S.M.4    Bell, D.5    Krahn, P.M.6    Evans, D.A.7
  • 29
    • 30344457586 scopus 로고    scopus 로고
    • A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants
    • Sim SC, Risinger C, Dahl ML, Aklillu E, Christensen M, Bertilsson L, Ingelman-Sundberg M (2006) A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants. Clin Pharmacol Ther 79:103-113
    • (2006) Clin Pharmacol Ther , vol.79 , pp. 103-113
    • Sim, S.C.1    Risinger, C.2    Dahl, M.L.3    Aklillu, E.4    Christensen, M.5    Bertilsson, L.6    Ingelman-Sundberg, M.7
  • 30
    • 33749339075 scopus 로고    scopus 로고
    • Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects
    • Hulot JS, Bura A, Villard E, Azizi M, Remones V, Goyenvalle C, Aiach M, Lechat P, Gaussem P (2006) Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects. Blood 108:2244-2247
    • (2006) Blood , vol.108 , pp. 2244-2247
    • Hulot, J.S.1    Bura, A.2    Villard, E.3    Azizi, M.4    Remones, V.5    Goyenvalle, C.6    Aiach, M.7    Lechat, P.8    Gaussem, P.9
  • 32
    • 0033608466 scopus 로고    scopus 로고
    • Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
    • Aithal GP, Day CP, Kesteven PJ, Daly AK (1999) Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet 353:717-719
    • (1999) Lancet , vol.353 , pp. 717-719
    • Aithal, G.P.1    Day, C.P.2    Kesteven, P.J.3    Daly, A.K.4
  • 35
  • 36
    • 0036336114 scopus 로고    scopus 로고
    • Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2
    • Kirchheiner J, Meineke I, Freytag G, Meisel C, Roots I, Brockmoller J (2002) Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2. Clin Pharmacol Ther 72:62-75
    • (2002) Clin Pharmacol Ther , vol.72 , pp. 62-75
    • Kirchheiner, J.1    Meineke, I.2    Freytag, G.3    Meisel, C.4    Roots, I.5    Brockmoller, J.6
  • 37
    • 0346784817 scopus 로고    scopus 로고
    • Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: No relationship to the CYP2C9 genetic polymorphism in humans
    • Kirchheiner J, Meineke I, Steinbach N, Meisel C, Roots I, Brockmoller J (2003) Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humans. Br J Clin Pharmacol 55:51-61
    • (2003) Br J Clin Pharmacol , vol.55 , pp. 51-61
    • Kirchheiner, J.1    Meineke, I.2    Steinbach, N.3    Meisel, C.4    Roots, I.5    Brockmoller, J.6
  • 40
    • 0036220552 scopus 로고    scopus 로고
    • Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteers
    • Kirchheiner J, Bauer S, Meineke I, Rohde W, Prang V, Meisel C, Roots I, Brockmöller J (2002) Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteers. Pharmacogenetics 12:101-109
    • (2002) Pharmacogenetics , vol.12 , pp. 101-109
    • Kirchheiner, J.1    Bauer, S.2    Meineke, I.3    Rohde, W.4    Prang, V.5    Meisel, C.6    Roots, I.7    Brockmöller, J.8
  • 41
    • 0036231580 scopus 로고    scopus 로고
    • Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers
    • Kirchheiner J, Brockmoller J, Meineke I, Bauer S, Rohde W, Meisel C, Roots I (2002) Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers. Clin Pharmacol Ther 71:286-296
    • (2002) Clin Pharmacol Ther , vol.71 , pp. 286-296
    • Kirchheiner, J.1    Brockmoller, J.2    Meineke, I.3    Bauer, S.4    Rohde, W.5    Meisel, C.6    Roots, I.7
  • 43
    • 21744439005 scopus 로고    scopus 로고
    • Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents
    • Holstein A, Plaschke A, Ptak M, Egberts EH, El-Din J, Brockmöller J, Kirchheiner J (2005) Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents. Br J Clin Pharmacol 60:103-106
    • (2005) Br J Clin Pharmacol , vol.60 , pp. 103-106
    • Holstein, A.1    Plaschke, A.2    Ptak, M.3    Egberts, E.H.4    El-Din, J.5    Brockmöller, J.6    Kirchheiner, J.7
  • 44
    • 11844304376 scopus 로고    scopus 로고
    • Clinical consequences of cytochrome P450 2C9 polymorphisms
    • Kirchheiner J, Brockmöller J (2005) Clinical consequences of cytochrome P450 2C9 polymorphisms. Clin Pharmacol Ther 77:1-16
    • (2005) Clin Pharmacol Ther , vol.77 , pp. 1-16
    • Kirchheiner, J.1    Brockmöller, J.2
  • 46
    • 0018822866 scopus 로고
    • Mercaptopurine pharmacogenetics: Monogenic inheritance of erythrocyte thiopurine methyltransferase activity
    • Weinshilboum RM, Sladek SL (1980) Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 32:651-662
    • (1980) Am J Hum Genet , vol.32 , pp. 651-662
    • Weinshilboum, R.M.1    Sladek, S.L.2
  • 47
    • 0027401302 scopus 로고
    • Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient
    • Schutz E, Gummert J, Mohr F, Oellerich M (1993) Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient. Lancet 341:436
    • (1993) Lancet , vol.341 , pp. 436
    • Schutz, E.1    Gummert, J.2    Mohr, F.3    Oellerich, M.4
  • 48
    • 33751103939 scopus 로고    scopus 로고
    • Adding pharmacogenetics information to drug labels: Lessons learned
    • Haga SB, Thummel KE, Burke W (2006) Adding pharmacogenetics information to drug labels: lessons learned. Pharmacogenet Genomics 16:847-854
    • (2006) Pharmacogenet Genomics , vol.16 , pp. 847-854
    • Haga, S.B.1    Thummel, K.E.2    Burke, W.3
  • 49
    • 31044434278 scopus 로고    scopus 로고
    • The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies
    • Woelderink A, Ibarreta D, Hopkins MM, Rodriguez-Cerezo E (2006) The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies. Pharmacogenomics J 6:3-7
    • (2006) Pharmacogenomics J , vol.6 , pp. 3-7
    • Woelderink, A.1    Ibarreta, D.2    Hopkins, M.M.3    Rodriguez-Cerezo, E.4
  • 52
    • 0031418165 scopus 로고    scopus 로고
    • Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity
    • Van Kuilenburg AB, Vreken P, Beex LV, Meinsma R, Van Lenthe H, De Abreu RA, van Gennip AH (1997) Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity. Eur J Cancer 33:2258-22564
    • (1997) Eur J Cancer , vol.33 , pp. 2258-22564
    • Van Kuilenburg, A.B.1    Vreken, P.2    Beex, L.V.3    Meinsma, R.4    Van Lenthe, H.5    De Abreu, R.A.6    Van Gennip, A.H.7
  • 54
    • 34548598459 scopus 로고    scopus 로고
    • UGT1A1*28 Genotype and Irinotecan-Induced Neutropenia: Dose Matters
    • (in press). DOI 10.1093/jnci/djm115
    • Hoskins JM, Goldberg RM, Qu P, Ibrahim JG, McLeod HL (2007) UGT1A1*28 Genotype and Irinotecan-Induced Neutropenia: Dose Matters. J Natl Cancer Inst (in press). DOI 10.1093/jnci/djm115
    • (2007) J Natl Cancer Inst
    • Hoskins, J.M.1    Goldberg, R.M.2    Qu, P.3    Ibrahim, J.G.4    McLeod, H.L.5
  • 55
    • 35348853741 scopus 로고    scopus 로고
    • The role of size and charge for blood-brain barrier permeation of drugs and Fatty acids
    • Seelig A (2007) The role of size and charge for blood-brain barrier permeation of drugs and Fatty acids. J Mol Neurosci 33:32-41
    • (2007) J Mol Neurosci , vol.33 , pp. 32-41
    • Seelig, A.1
  • 57
    • 33846568546 scopus 로고    scopus 로고
    • ABCB1 pharmacogenetics: Progress, pitfalls, and promise
    • Chinn LW, Kroetz DL (2007) ABCB1 pharmacogenetics: progress, pitfalls, and promise. Clin Pharmacol Ther 81:265-269
    • (2007) Clin Pharmacol Ther , vol.81 , pp. 265-269
    • Chinn, L.W.1    Kroetz, D.L.2
  • 58
    • 34249058785 scopus 로고    scopus 로고
    • ABCB1 genotype and PGP expression, function and therapeutic drug response: A critical review and recommendations for future research
    • Leschziner GD, Andrew T, Pirmohamed M, Johnson MR (2007) ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research. Pharmacogenom J 7:154-179
    • (2007) Pharmacogenom J , vol.7 , pp. 154-179
    • Leschziner, G.D.1    Andrew, T.2    Pirmohamed, M.3    Johnson, M.R.4
  • 59
    • 0035929574 scopus 로고    scopus 로고
    • Polymorphisms in OATP-C: Identification of multiple allelic variants associated with altered transport activity among European- and African-Americans
    • Tirona RG, Leake BF, Merino G, Kim RB (2001) Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans. J Biol Chem 276:35669-35675
    • (2001) J Biol Chem , vol.276 , pp. 35669-35675
    • Tirona, R.G.1    Leake, B.F.2    Merino, G.3    Kim, R.B.4
  • 60
    • 2042469487 scopus 로고    scopus 로고
    • Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics
    • Mwinyi J, Johne A, Bauer S, Roots I, Gerloff T (2004) Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics. Clin Pharmacol Ther 75:415-421
    • (2004) Clin Pharmacol Ther , vol.75 , pp. 415-421
    • Mwinyi, J.1    Johne, A.2    Bauer, S.3    Roots, I.4    Gerloff, T.5
  • 61
    • 39149130393 scopus 로고    scopus 로고
    • The polymorphisms Asn130Asp and Val174Ala in the organic anion transporting polypeptide OATP1B1 independently affect torsemide pharmacokinetics and -dynamics
    • (in press)
    • Vormfelde SV, Toliat MR, Schirmer M, Meineke I, Nürnberg P, Brockmöller J (2007) The polymorphisms Asn130Asp and Val174Ala in the organic anion transporting polypeptide OATP1B1 independently affect torsemide pharmacokinetics and -dynamics. Clin Pharmacol Ther (in press)
    • (2007) Clin Pharmacol Ther
    • Vormfelde, S.V.1    Toliat, M.R.2    Schirmer, M.3    Meineke, I.4    Nürnberg, P.5    Brockmöller, J.6
  • 68
    • 0033832449 scopus 로고    scopus 로고
    • Pharmacogenetics of beta-1- and beta-2-adrenergic receptors
    • Liggett SB (2000) Pharmacogenetics of beta-1- and beta-2-adrenergic receptors. Pharmacology 61:167-173
    • (2000) Pharmacology , vol.61 , pp. 167-173
    • Liggett, S.B.1
  • 69
    • 0033617342 scopus 로고    scopus 로고
    • A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor
    • Mason DA, Moore JD, Green SA, Liggett SB (1999) A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem 274:12670-12674
    • (1999) J Biol Chem , vol.274 , pp. 12670-12674
    • Mason, D.A.1    Moore, J.D.2    Green, S.A.3    Liggett, S.B.4
  • 70
    • 33845973320 scopus 로고    scopus 로고
    • Real-time optical recording of beta1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol
    • Rochais F, Vilardaga JP, Nikolaev VO, Bunemann M, Lohse MJ, Engelhardt S (2007) Real-time optical recording of beta1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol. J Clin Invest 117:229-235
    • (2007) J Clin Invest , vol.117 , pp. 229-235
    • Rochais, F.1    Vilardaga, J.P.2    Nikolaev, V.O.3    Bunemann, M.4    Lohse, M.J.5    Engelhardt, S.6
  • 71
    • 0141706946 scopus 로고    scopus 로고
    • The Gly389Arg beta1-adrenergic receptor polymorphism: A predictor of response to beta-blocker treatment?
    • Brodde OE, Stein CM (2003) The Gly389Arg beta1-adrenergic receptor polymorphism: a predictor of response to beta-blocker treatment? Clin Pharmacol Ther 74:299-302
    • (2003) Clin Pharmacol Ther , vol.74 , pp. 299-302
    • Brodde, O.E.1    Stein, C.M.2
  • 72
    • 34548720439 scopus 로고    scopus 로고
    • Pharmacogenetics of the response to beta2-agnoist drugs: A systematic overview of the field
    • Contopoulos-Ioannidis DG, Kouri I, Ioannidis JPA (2007) Pharmacogenetics of the response to beta2-agnoist drugs: A systematic overview of the field. Pharmacoeconomics 8:933-958
    • (2007) Pharmacoeconomics , vol.8 , pp. 933-958
    • Contopoulos-Ioannidis, D.G.1    Kouri, I.2    Ioannidis, J.P.A.3
  • 75
    • 34249016361 scopus 로고    scopus 로고
    • The convergence of conventional therapeutic drug monitoring and pharmacogenetic testing in personalized medicine: Focus on antidepressants
    • Sjoqvist F, Eliasson E (2007) The convergence of conventional therapeutic drug monitoring and pharmacogenetic testing in personalized medicine: focus on antidepressants. Clin Pharmacol Ther 81:899-902
    • (2007) Clin Pharmacol Ther , vol.81 , pp. 899-902
    • Sjoqvist, F.1    Eliasson, E.2
  • 77
    • 3142519666 scopus 로고    scopus 로고
    • Pharmacogenetics of antidepressants and antipsychotics: The contribution of allelic variations to the phenotype of drug response
    • Kirchheiner J, Nickchen K, Bauer M, Wong ML, Licinio J, Roots I, Brockmoller J (2004) Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Mol Psychiatry 9:442-473
    • (2004) Mol Psychiatry , vol.9 , pp. 442-473
    • Kirchheiner, J.1    Nickchen, K.2    Bauer, M.3    Wong, M.L.4    Licinio, J.5    Roots, I.6    Brockmoller, J.7
  • 80
    • 38049093868 scopus 로고    scopus 로고
    • CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: A prospective randomized controlled study
    • (in press). Epub: 12 Sept 2007.
    • Caraco Y, Blotnick S, Muszkat M (2007) CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study. Clin Pharmacol Ther (in press). Epub: 12 Sept 2007.
    • (2007) Clin Pharmacol Ther
    • Caraco, Y.1    Blotnick, S.2    Muszkat, M.3
  • 81
    • 34249715284 scopus 로고    scopus 로고
    • Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation
    • Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S (2007) Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 115:2689-2696
    • (2007) Circulation , vol.115 , pp. 2689-2696
    • Hylek, E.M.1    Evans-Molina, C.2    Shea, C.3    Henault, L.E.4    Regan, S.5
  • 82
    • 11044228905 scopus 로고    scopus 로고
    • A systematic review of cost-effectiveness analyses of pharmacogenomic interventions
    • Phillips KA, Van Bebber SL (2004) A systematic review of cost-effectiveness analyses of pharmacogenomic interventions. Pharmacogenomics 5:1139-1149
    • (2004) Pharmacogenomics , vol.5 , pp. 1139-1149
    • Phillips, K.A.1    Van Bebber, S.L.2
  • 84
    • 0021130765 scopus 로고
    • Metabolic oxidation phenotypes as markers for susceptibility to lung cancer
    • Ayesh R, Idle JR, Ritchie JC, Crothers MJ, Hetzel MR (1984) Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature 312:169-170
    • (1984) Nature , vol.312 , pp. 169-170
    • Ayesh, R.1    Idle, J.R.2    Ritchie, J.C.3    Crothers, M.J.4    Hetzel, M.R.5
  • 85
    • 0023795221 scopus 로고
    • Debrisoquine hydroxylation phenotype, acetylation phenotype, and ABO blood groups as genetic host factors of lung cancer risk
    • Suppl 11
    • Roots I, Drakoulis N, Ploch M, Heinemeyer G, Loddenkemper R, Minks T, Nitz M, Otte F, Koch M (1988) Debrisoquine hydroxylation phenotype, acetylation phenotype, and ABO blood groups as genetic host factors of lung cancer risk. Klin Wochenschr 66[Suppl 11]:87-97
    • (1988) Klin Wochenschr , vol.66 , pp. 87-97
    • Roots, I.1    Drakoulis, N.2    Ploch, M.3    Heinemeyer, G.4    Loddenkemper, R.5    Minks, T.6    Nitz, M.7    Otte, F.8    Koch, M.9
  • 86
    • 0010325553 scopus 로고
    • Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion
    • Seidegard J, Vorachek WR, Pero RW, Pearson WR (1988) Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 85:7293-7297
    • (1988) Proc Natl Acad Sci USA , vol.85 , pp. 7293-7297
    • Seidegard, J.1    Vorachek, W.R.2    Pero, R.W.3    Pearson, W.R.4
  • 90
    • 79959524146 scopus 로고    scopus 로고
    • A haplotype map of the human genome
    • The International HapMap Consortium
    • The International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437:1299-320
    • (2005) Nature , vol.437 , pp. 1299-320
  • 93
    • 0033945594 scopus 로고    scopus 로고
    • Dopamine D4 receptor 48-bp repeat polymorphism: No association with response to antipsychotic treatment, but association with catatonic schizophrenia
    • Kaiser R, Konneker M, Henneken M, Dettling M, Muller-Oerlinghausen B, Roots I, Brockmoller J (2000) Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophrenia. Mol Psychiatry 5:418-424
    • (2000) Mol Psychiatry , vol.5 , pp. 418-424
    • Kaiser, R.1    Konneker, M.2    Henneken, M.3    Dettling, M.4    Muller-Oerlinghausen, B.5    Roots, I.6    Brockmoller, J.7
  • 94
    • 33845506859 scopus 로고    scopus 로고
    • Tissue-specific alternative promoters of the serotonin receptor gene HTR3B in human brain and intestine
    • Tzvetkov MV, Meineke C, Oetjen E, Hirsch-Ernst K, Brockmoller J (2007) Tissue-specific alternative promoters of the serotonin receptor gene HTR3B in human brain and intestine. Gene 386:52-62
    • (2007) Gene , vol.386 , pp. 52-62
    • Tzvetkov, M.V.1    Meineke, C.2    Oetjen, E.3    Hirsch-Ernst, K.4    Brockmoller, J.5
  • 97
    • 29444450702 scopus 로고    scopus 로고
    • Common deletions and SNPs are in linkage disequilibrium in the human genome
    • Hinds DA, Kloek AP, Jen M, Chen X, Frazer KA (2006) Common deletions and SNPs are in linkage disequilibrium in the human genome. Nat Genet 38:82-85
    • (2006) Nat Genet , vol.38 , pp. 82-85
    • Hinds, D.A.1    Kloek, A.P.2    Jen, M.3    Chen, X.4    Frazer, K.A.5
  • 101
    • 34447569298 scopus 로고    scopus 로고
    • Copy number variants and genetic traits: Closer to the resolution of phenotypic to genotypic variability
    • Beckmann JS, Estivill X, Antonarakis SE (2007) Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability. Nat Rev Genet 8:639-646
    • (2007) Nat Rev Genet , vol.8 , pp. 639-646
    • Beckmann, J.S.1    Estivill, X.2    Antonarakis, S.E.3
  • 103
    • 0346363770 scopus 로고    scopus 로고
    • CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR
    • Schaeffeler E, Schwab M, Eichelbaum M, Zanger UM (2003) CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR. Hum Mutat 22:476-485
    • (2003) Hum Mutat , vol.22 , pp. 476-485
    • Schaeffeler, E.1    Schwab, M.2    Eichelbaum, M.3    Zanger, U.M.4
  • 104
    • 0033816360 scopus 로고    scopus 로고
    • Characterization of the glutathione S-transferase GSTT1 deletion: Discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation
    • Sprenger R, Schlagenhaufer R, Kerb R, Bruhn C, Brockmoller J, Roots I, Brinkmann U (2000) Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation. Pharmacogenetics 10:557-565
    • (2000) Pharmacogenetics , vol.10 , pp. 557-565
    • Sprenger, R.1    Schlagenhaufer, R.2    Kerb, R.3    Bruhn, C.4    Brockmoller, J.5    Roots, I.6    Brinkmann, U.7
  • 105
    • 23044474063 scopus 로고    scopus 로고
    • Karyotypic abnormalities create discordance of germline genotype and cancer cell phenotypes
    • Cheng Q, Yang W, Raimondi SC, Pui CH, Relling MV, Evans WE (2005) Karyotypic abnormalities create discordance of germline genotype and cancer cell phenotypes. Nat Genet 37:878-882
    • (2005) Nat Genet , vol.37 , pp. 878-882
    • Cheng, Q.1    Yang, W.2    Raimondi, S.C.3    Pui, C.H.4    Relling, M.V.5    Evans, W.E.6
  • 107
    • 33846534679 scopus 로고    scopus 로고
    • Epigenetic gene regulation: Early environmental exposures
    • Dolinoy DC (2007) Epigenetic gene regulation: early environmental exposures. Pharmacogenomics 8:5-10
    • (2007) Pharmacogenomics , vol.8 , pp. 5-10
    • Dolinoy, D.C.1
  • 108
    • 0034050905 scopus 로고    scopus 로고
    • Known variant DPYD alleles do not explain DPD deficiency in cancer patients
    • Collie-Duguid ES, Etienne MC, Milano G, McLeod HL (2000) Known variant DPYD alleles do not explain DPD deficiency in cancer patients. Pharmacogenetics 10:217-223
    • (2000) Pharmacogenetics , vol.10 , pp. 217-223
    • Collie-Duguid, E.S.1    Etienne, M.C.2    Milano, G.3    McLeod, H.L.4
  • 109
    • 0034901306 scopus 로고    scopus 로고
    • Lethal outcome of a patient with a complete dihydropyrimidine dehydrogenase (DPD) deficiency after administration of 5-fluorouracil: Frequency of the common IVS14+1G>A mutation causing DPD deficiency
    • van Kuilenburg AB, Muller EW, Haasjes J, Meinsma R, Zoetekouw L, Waterham HR, Baas F, Richel DJ, van Gennip AH (2001) Lethal outcome of a patient with a complete dihydropyrimidine dehydrogenase (DPD) deficiency after administration of 5-fluorouracil: frequency of the common IVS14+1G>A mutation causing DPD deficiency. Clin Cancer Res 7:1149-1153
    • (2001) Clin Cancer Res , vol.7 , pp. 1149-1153
    • Van Kuilenburg, A.B.1    Muller, E.W.2    Haasjes, J.3    Meinsma, R.4    Zoetekouw, L.5    Waterham, H.R.6    Baas, F.7    Richel, D.J.8    Van Gennip, A.H.9
  • 110
    • 29344443013 scopus 로고    scopus 로고
    • Methylation of the DPYD promoter: An alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patients
    • Ezzeldin HH, Lee AM, Mattison LK, Diasio RB (2005) Methylation of the DPYD promoter: an alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patients. Clin Cancer Res 11:8699-8705
    • (2005) Clin Cancer Res , vol.11 , pp. 8699-8705
    • Ezzeldin, H.H.1    Lee, A.M.2    Mattison, L.K.3    Diasio, R.B.4
  • 112
    • 16344366323 scopus 로고    scopus 로고
    • Gene expression profiling of the irinotecan pathway in colorectal cancer
    • Yu J, Shannon WD, Watson MA, McLeod HL (2005) Gene expression profiling of the irinotecan pathway in colorectal cancer. Clin Cancer Res 11:2053-2062
    • (2005) Clin Cancer Res , vol.11 , pp. 2053-2062
    • Yu, J.1    Shannon, W.D.2    Watson, M.A.3    McLeod, H.L.4
  • 113
    • 33947587702 scopus 로고    scopus 로고
    • Suppression of DPYD expression in RKO cells via DNA methylation in the regulatory region of the DPYD promoter: A potentially important epigenetic mechanism regulating DPYD expression
    • Zhang X, Soong R, Wang K, Li L, Davie JR, Guarcello V, Diasio RB (2007) Suppression of DPYD expression in RKO cells via DNA methylation in the regulatory region of the DPYD promoter: a potentially important epigenetic mechanism regulating DPYD expression. Biochem Cell Biol 85:337-346
    • (2007) Biochem Cell Biol , vol.85 , pp. 337-346
    • Zhang, X.1    Soong, R.2    Wang, K.3    Li, L.4    Davie, J.R.5    Guarcello, V.6    Diasio, R.B.7
  • 115
    • 0027751663 scopus 로고
    • The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
    • Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-854
    • (1993) Cell , vol.75 , pp. 843-854
    • Lee, R.C.1    Feinbaum, R.L.2    Ambros, V.3
  • 117
    • 34247468830 scopus 로고    scopus 로고
    • The maternal-zygotic transition: Death and birth of RNAs
    • Schier AF (2007) The maternal-zygotic transition: death and birth of RNAs. Science 316:406-407
    • (2007) Science , vol.316 , pp. 406-407
    • Schier, A.F.1
  • 118
    • 34547727263 scopus 로고    scopus 로고
    • Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: A mechanism for functional single-nucleotide polymorphisms related to phenotypes
    • Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS, Hatzigeorgiou AG, Antonarakis SE (2007) Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 81:405-413
    • (2007) Am J Hum Genet , vol.81 , pp. 405-413
    • Sethupathy, P.1    Borel, C.2    Gagnebin, M.3    Grant, G.R.4    Deutsch, S.5    Elton, T.S.6    Hatzigeorgiou, A.G.7    Antonarakis, S.E.8
  • 119
    • 3242677639 scopus 로고    scopus 로고
    • SiRNAs: Applications in functional genomics and potential as therapeutics
    • Dorsett Y, Tuschl T (2004) siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 3:318-329
    • (2004) Nat Rev Drug Discov , vol.3 , pp. 318-329
    • Dorsett, Y.1    Tuschl, T.2
  • 120
    • 33645226480 scopus 로고    scopus 로고
    • Allele-specific silencing of Alzheimer's disease genes: The amyloid precursor protein genes with Swedish or London mutations
    • Feng X, Zhao P, He Y, Zuo Z (2006) Allele-specific silencing of Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London mutations. Gene 371:68-74
    • (2006) Gene , vol.371 , pp. 68-74
    • Feng, X.1    Zhao, P.2    He, Y.3    Zuo, Z.4
  • 121
    • 27744533560 scopus 로고    scopus 로고
    • Silencing primary dystonia: Lentiviral-mediated RNA interference therapy for DYT1 dystonia
    • Gonzalez-Alegre P, Bode N, Davidson BL, Paulson HL (2005) Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystonia. J Neurosci 25:10502-10509
    • (2005) J Neurosci , vol.25 , pp. 10502-10509
    • Gonzalez-Alegre, P.1    Bode, N.2    Davidson, B.L.3    Paulson, H.L.4
  • 123
    • 33747201641 scopus 로고    scopus 로고
    • Allele-specific RNAi selectively silences mutant SOD1 and achieves significant therapeutic benefit in vivo
    • Xia X, Zhou H, Huang Y, Xu Z (2006) Allele-specific RNAi selectively silences mutant SOD1 and achieves significant therapeutic benefit in vivo. Neurobiol Dis 23:578-586
    • (2006) Neurobiol Dis , vol.23 , pp. 578-586
    • Xia, X.1    Zhou, H.2    Huang, Y.3    Xu, Z.4
  • 124
    • 33645160450 scopus 로고    scopus 로고
    • Allele-specific RNA interference for neurological disease
    • Rodriguez-Lebron E, Paulson HL (2006) Allele-specific RNA interference for neurological disease. Gene Ther 13:576-581
    • (2006) Gene Ther , vol.13 , pp. 576-581
    • Rodriguez-Lebron, E.1    Paulson, H.L.2
  • 126
    • 33646373728 scopus 로고    scopus 로고
    • Estrogen receptor testing of breast cancer in current clinical practice: What's the question?
    • Schnitt SJ (2006) Estrogen receptor testing of breast cancer in current clinical practice: what's the question? J Clin Oncol 24:1797-1799
    • (2006) J Clin Oncol , vol.24 , pp. 1797-1799
    • Schnitt, S.J.1
  • 129
    • 23444450588 scopus 로고    scopus 로고
    • Evaluation of the quantitative analytical methods real-time PCR for HER-2 gene quantification and ELISA of serum HER-2 protein and comparison with fluorescence in situ hybridization and immunohistochemistry for determining HER-2 status in breast cancer patients
    • Tse C, Brault D, Gligorov J, Antoine M, Neumann R, Lotz JP, Capeau J (2005) Evaluation of the quantitative analytical methods real-time PCR for HER-2 gene quantification and ELISA of serum HER-2 protein and comparison with fluorescence in situ hybridization and immunohistochemistry for determining HER-2 status in breast cancer patients. Clin Chem 51:1093-1101
    • (2005) Clin Chem , vol.51 , pp. 1093-1101
    • Tse, C.1    Brault, D.2    Gligorov, J.3    Antoine, M.4    Neumann, R.5    Lotz, J.P.6    Capeau, J.7
  • 131
    • 33644840600 scopus 로고    scopus 로고
    • Acute lymphoblastic leukaemia: A model for the pharmacogenomics of cancer therapy
    • Cheok MH, Evans WE (2006) Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy. Nat Rev Cancer 6:117-129
    • (2006) Nat Rev Cancer , vol.6 , pp. 117-129
    • Cheok, M.H.1    Evans, W.E.2
  • 132
    • 34249690154 scopus 로고    scopus 로고
    • Microarray analysis to reveal genes involved in colon carcinogenesis
    • Joyce T, Pintzas A (2007) Microarray analysis to reveal genes involved in colon carcinogenesis. Expert Opin Pharmacother 8:895-900
    • (2007) Expert Opin Pharmacother , vol.8 , pp. 895-900
    • Joyce, T.1    Pintzas, A.2
  • 133
    • 34250217011 scopus 로고    scopus 로고
    • Expression genomics in breast cancer research: Microarrays at the crossroads of biology and medicine
    • Miller LD, Liu ET (2007) Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine. Breast Cancer Res 9:206
    • (2007) Breast Cancer Res , vol.9 , pp. 206
    • Miller, L.D.1    Liu, E.T.2
  • 137
    • 34347344976 scopus 로고    scopus 로고
    • A new multipoint method for genome-wide association studies by imputation of genotypes
    • Marchini J, Howie B, Myers S, McVean G, Donnelly P (2007) A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39:906-913
    • (2007) Nat Genet , vol.39 , pp. 906-913
    • Marchini, J.1    Howie, B.2    Myers, S.3    McVean, G.4    Donnelly, P.5
  • 139
    • 13444269543 scopus 로고    scopus 로고
    • Haploview: Analysis and visualization of LD and haplotype maps
    • Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265
    • (2005) Bioinformatics , vol.21 , pp. 263-265
    • Barrett, J.C.1    Fry, B.2    Maller, J.3    Daly, M.J.4
  • 149
    • 84969213492 scopus 로고    scopus 로고
    • Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
    • he Wellcome Trust Case Control Consortium
    • he Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661-678
    • (2007) Nature , vol.447 , pp. 661-678
  • 156
    • 33947396419 scopus 로고    scopus 로고
    • Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy
    • Huang Y (2007) Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy. Cancer Metastasis Rev 26:183-201
    • (2007) Cancer Metastasis Rev , vol.26 , pp. 183-201
    • Huang, Y.1
  • 160
    • 37349093654 scopus 로고    scopus 로고
    • Pharmacogenetic studies in depression: A proposal for methodologic guidelines
    • Serretti A, Kato M, Kennedy JL (2007) Pharmacogenetic studies in depression: a proposal for methodologic guidelines. Pharmacogenomics J
    • (2007) Pharmacogenomics J
    • Serretti, A.1    Kato, M.2    Kennedy, J.L.3
  • 162
    • 18044371615 scopus 로고    scopus 로고
    • Use of CEPH and non-CEPH lymphoblast cell lines in pharmacogenetic studies
    • Shukla SJ, Dolan ME (2005) Use of CEPH and non-CEPH lymphoblast cell lines in pharmacogenetic studies. Pharmacogenomics 6:303-310
    • (2005) Pharmacogenomics , vol.6 , pp. 303-310
    • Shukla, S.J.1    Dolan, M.E.2
  • 163
    • 23844542866 scopus 로고    scopus 로고
    • Drug-induced QT interval prolongation-regulatory guidance and perspectives on hERG channel studies
    • Shah RR (2005) Drug-induced QT interval prolongation-regulatory guidance and perspectives on hERG channel studies. Novartis Found Symp 266:251-280 discussion 280-285
    • (2005) Novartis Found Symp , vol.266 , pp. 251-280
    • Shah, R.R.1
  • 164
    • 0142209375 scopus 로고    scopus 로고
    • Genomic priorities and public health
    • Merikangas KR, Risch N (2003) Genomic priorities and public health. Science 302:599-601
    • (2003) Science , vol.302 , pp. 599-601
    • Merikangas, K.R.1    Risch, N.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.